Literature DB >> 26752231

BCL-2 protects human and mouse Th17 cells from glucocorticoid-induced apoptosis.

J Banuelos1, S Shin1, Y Cao1, B S Bochner1, L Morales-Nebreda2, G R S Budinger2, L Zhou3, S Li4, J Xin4, M W Lingen4, C Dong5, R P Schleimer1, N Z Lu1.   

Abstract

BACKGROUND: Glucocorticoid resistance has been associated with Th17-driven inflammation, the mechanisms of which are not clear. We determined whether human and mouse Th17 cells are resistant to glucocorticoid-induced apoptosis.
METHODS: Freshly isolated human blood Th17 cells and in vitro differentiated Th17 cells from IL-17F red fluorescent protein reporter mice were treated with dexamethasone, a potent glucocorticoid. Apoptosis was measured using annexin V and DAPI staining. Screening of apoptosis genes was performed using the apoptosis PCR array. Levels of molecules involved in apoptosis were measured using quantitative RT-PCR, flow cytometry, and Western blotting. Knockdown of BCL-2 in murine Th17 cells was performed via retroviral transduction. Cytokines were measured using ELISA. A murine Th17-driven severe asthma model was examined for Th17 glucocorticoid sensitivity in vivo.
RESULTS: Human and mouse Th17 cells and mouse Th2 cells were resistant to glucocorticoid-induced apoptosis. Th17 cells had glucocorticoid receptors levels comparable to those in other T effectors cells. Th17 cells had high levels of BCL-2, knockdown of which sensitized Th17 cells to dexamethasone-induced apoptosis. Production of IL-22, but not IL-17A and IL-17F, was suppressed by glucocorticoids. STAT3 phosphorylation in Th17 cells was insensitive to glucocorticoid inhibition. Lung Th17 cells in the murine severe asthma model were enhanced, rather than suppressed, by glucocorticoids.
CONCLUSION: Th17 cells are resistant to glucocorticoid-induced apoptosis and cytokine suppression, at least in part due to high levels of BCL-2. These findings support a role of Th17 cells in glucocorticoid-resistant inflammatory conditions such as certain endotypes of asthma.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T cells; Th17 cells; apoptosis; asthma; glucocorticoids

Mesh:

Substances:

Year:  2016        PMID: 26752231      PMCID: PMC4844778          DOI: 10.1111/all.12840

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  45 in total

1.  Nasal IL-17F is related to bronchial IL-17F/neutrophilia and exacerbations in stable atopic severe asthma.

Authors:  V Sorbello; G Ciprandi; A Di Stefano; G M Massaglia; G Favatà; S Conticello; M Malerba; G Folkerts; M Profita; G Rolla; F L M Ricciardolo
Journal:  Allergy       Date:  2015-02       Impact factor: 13.146

2.  Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma.

Authors:  Chaoyu Irvin; Iram Zafar; James Good; Donald Rollins; Christina Christianson; Magdalena M Gorska; Richard J Martin; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2014-07-18       Impact factor: 10.793

3.  Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A.

Authors:  Lauren P Schewitz-Bowers; Philippa J P Lait; David A Copland; Ping Chen; Wenting Wu; Ashwin D Dhanda; Barbara P Vistica; Emily L Williams; Baoying Liu; Shayma Jawad; Zhiyu Li; William Tucker; Sima Hirani; Yoshiyuki Wakabayashi; Jun Zhu; Nida Sen; Becky L Conway-Campbell; Igal Gery; Andrew D Dick; Lai Wei; Robert B Nussenblatt; Richard W J Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

4.  A hotspot in the glucocorticoid receptor DNA-binding domain susceptible to loss of function mutation.

Authors:  Jesus Banuelos; Soon Cheon Shin; Nick Z Lu
Journal:  Steroids       Date:  2015-02-09       Impact factor: 2.668

5.  Endogenous interleukin-6 amplifies interleukin-17 production and corticoid-resistance in peripheral T cells from patients with multiple sclerosis.

Authors:  Thais B Ferreira; Joana Hygino; Priscila O Barros; Bruna Teixeira; Taissa M Kasahara; Ulisses C Linhares; Lana Márcia F Lopes; Claudia Cristina F Vasconcelos; Regina Alvarenga; Ana Cristina Wing; Regis M Andrade; Arnaldo F B Andrade; Cleonice A M Bento
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

6.  Glucocorticoids induce the production of the chemoattractant CCL20 in airway epithelium.

Authors:  G Jan Zijlstra; Fatemeh Fattahi; Dennie Rozeveld; Marnix R Jonker; Nathalie M Kliphuis; Maarten van den Berge; Machteld N Hylkema; Nick H T ten Hacken; Antoon J M van Oosterhout; Irene H Heijink
Journal:  Eur Respir J       Date:  2014-03-13       Impact factor: 16.671

7.  Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M.

Authors:  Masanori Miyata; Ji-Yun Lee; Seiko Susuki-Miyata; Wenzhuo Y Wang; Haidong Xu; Hirofumi Kai; Koichi S Kobayashi; Richard A Flavell; Jian-Dong Li
Journal:  Nat Commun       Date:  2015-01-14       Impact factor: 14.919

8.  Distinct endotypes of steroid-resistant asthma characterized by IL-17A(high) and IFN-γ(high) immunophenotypes: Potential benefits of calcitriol.

Authors:  Emma S Chambers; Alexandra M Nanzer; Paul E Pfeffer; David F Richards; Peter M Timms; Adrian R Martineau; Christopher J Griffiths; Christopher J Corrigan; Catherine M Hawrylowicz
Journal:  J Allergy Clin Immunol       Date:  2015-03-13       Impact factor: 10.793

9.  FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients.

Authors:  M T Cencioni; S Santini; G Ruocco; G Borsellino; M De Bardi; M G Grasso; S Ruggieri; C Gasperini; D Centonze; D Barilá; L Battistini; E Volpe
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

Review 10.  Th17-associated cytokines as a therapeutic target for steroid-insensitive asthma.

Authors:  Yuko Morishima; Satoshi Ano; Yukio Ishii; Shigeo Ohtsuka; Masashi Matsuyama; Mio Kawaguchi; Nobuyuki Hizawa
Journal:  Clin Dev Immunol       Date:  2013-12-23
View more
  28 in total

Review 1.  Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease.

Authors:  Tomomi Toubai; John Magenau
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 2.  A gradient of glucocorticoid sensitivity among helper T cell cytokines.

Authors:  Jesus Banuelos; Nicholas Z Lu
Journal:  Cytokine Growth Factor Rev       Date:  2016-05-13       Impact factor: 7.638

Review 3.  Immunopathology alters Th17 cell glucocorticoid sensitivity.

Authors:  J Banuelos; Y Cao; S C Shin; N Z Lu
Journal:  Allergy       Date:  2016-10-13       Impact factor: 13.146

Review 4.  Glucocorticoids in T cell development, differentiation and function.

Authors:  Matthew D Taves; Jonathan D Ashwell
Journal:  Nat Rev Immunol       Date:  2020-11-04       Impact factor: 53.106

Review 5.  Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases.

Authors:  Ioana Agache; Cezmi A Akdis
Journal:  J Clin Invest       Date:  2019-03-11       Impact factor: 14.808

Review 6.  The immunopathobiology of T cells in stress condition: a review.

Authors:  Mostafa Khedri; Azam Samei; Mahdi Fasihi-Ramandi; Ramezan Ali Taheri
Journal:  Cell Stress Chaperones       Date:  2020-04-21       Impact factor: 3.667

7.  CD161 contributes to prenatal immune suppression of IFNγ-producing PLZF+ T cells.

Authors:  Joanna Halkias; Elze Rackaityte; Sara L Hillman; Dvir Aran; Ventura F Mendoza; Lucy R Marshall; Tippi C MacKenzie; Trevor D Burt
Journal:  J Clin Invest       Date:  2019-05-30       Impact factor: 14.808

8.  Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells.

Authors:  Scott N Furlan; Benjamin Watkins; Victor Tkachev; Sarah Cooley; Angela Panoskaltsis-Mortari; Kayla Betz; Melanie Brown; Daniel J Hunt; John B Schell; Katie Zeleski; Alison Yu; Cynthia R Giver; Edmund K Waller; Jeffrey S Miller; Bruce R Blazar; Leslie S Kean
Journal:  Blood       Date:  2016-10-06       Impact factor: 22.113

9.  Glucocorticoids Inhibit Group 3 Innate Lymphocyte IL-22 Production.

Authors:  Sudarshan Seshadri; Rosemary L Pope; Lauren A Zenewicz
Journal:  J Immunol       Date:  2018-07-06       Impact factor: 5.422

10.  Effect of systemic steroid therapy in Graves' orbitopathy on regulatory T cells and Th17/Treg ratio.

Authors:  M Siomkajło; Ł Mizera; D Szymczak; K Kolačkov; J Grzegrzółka; M Bolanowski; J Daroszewski
Journal:  J Endocrinol Invest       Date:  2021-04-17       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.